Literature DB >> 30778177

Neuroendocrine prostate carcinoma cells originate from the p63-expressing basal cells but not the pre-existing adenocarcinoma cells in mice.

Dong-Kee Lee1, Yonghong Liu1,2, Lan Liao1, Wenliang Li3, David Danielpour4, Jianming Xu5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30778177      PMCID： PMC6796947          DOI： 10.1038/s41422-019-0149-4

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

1.  Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

Authors:  Min Zou; Roxanne Toivanen; Antonina Mitrofanova; Nicolas Floch; Sheida Hayati; Yanping Sun; Clémentine Le Magnen; Daniel Chester; Elahe A Mostaghel; Andrea Califano; Mark A Rubin; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Discov       Date:  2017-04-14       Impact factor: 39.397

2.  Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).

Authors:  Yezi Zhu; Chengfei Liu; Yuanyuan Cui; Nagalakshmi Nadiminty; Wei Lou; Allen C Gao
Journal:  Prostate       Date:  2014-05-12       Impact factor: 4.104

3.  Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice.

Authors:  Yan Hu; Joseph E Ippolito; Emily M Garabedian; Peter A Humphrey; Jeffrey I Gordon
Journal:  J Biol Chem       Date:  2002-09-11       Impact factor: 5.157

4.  Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.

Authors:  Ganesh S Palapattu; Chengyu Wu; Christopher R Silvers; Heather B Martin; Karin Williams; Linda Salamone; Timothy Bushnell; Li-Shan Huang; Qi Yang; Jiaoti Huang
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

5.  Prostate cancer in a transgenic mouse.

Authors:  N M Greenberg; F DeMayo; M J Finegold; D Medina; W D Tilley; J O Aspinall; G R Cunha; A A Donjacour; R J Matusik; J M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

Review 6.  Aggressive variants of castration-resistant prostate cancer.

Authors:  Himisha Beltran; Scott Tomlins; Ana Aparicio; Vivek Arora; David Rickman; Gustavo Ayala; Jiaoti Huang; Lawrence True; Martin E Gleave; Howard Soule; Christopher Logothetis; Mark A Rubin
Journal:  Clin Cancer Res       Date:  2014-04-11       Impact factor: 12.531

7.  The steroid receptor coactivator-3 is required for developing neuroendocrine tumor in the mouse prostate.

Authors:  Jean Ching-Yi Tien; Lan Liao; Yonghong Liu; Zhaoliang Liu; Dong-Kee Lee; Fen Wang; Jianming Xu
Journal:  Int J Biol Sci       Date:  2014-10-02       Impact factor: 6.580

8.  Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta.

Authors:  D Danielpour
Journal:  J Cell Sci       Date:  1999-01       Impact factor: 5.285

9.  REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.

Authors:  Charlotte Svensson; Jens Ceder; Diego Iglesias-Gato; Yin-Choy Chuan; See Tong Pang; Anders Bjartell; Roxana Merino Martinez; Laura Bott; Leszek Helczynski; David Ulmert; Yuzhuo Wang; Yuanjie Niu; Colin Collins; Amilcar Flores-Morales
Journal:  Nucleic Acids Res       Date:  2013-10-24       Impact factor: 16.971

10.  The prostate basal cell (BC) heterogeneity and the p63-positive BC differentiation spectrum in mice.

Authors:  Dong-Kee Lee; Yonghong Liu; Lan Liao; Fen Wang; Jianming Xu
Journal:  Int J Biol Sci       Date:  2014-09-06       Impact factor: 6.580
  10 in total
  4 in total

Review 1.  Lineage plasticity in cancer: a shared pathway of therapeutic resistance.

Authors:  Álvaro Quintanal-Villalonga; Joseph M Chan; Helena A Yu; Dana Pe'er; Charles L Sawyers; Triparna Sen; Charles M Rudin
Journal:  Nat Rev Clin Oncol       Date:  2020-03-09       Impact factor: 66.675

2.  Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.

Authors:  Baijun Dong; Juju Miao; Yanqing Wang; Wenqin Luo; Zhongzhong Ji; Huadong Lai; Man Zhang; Xiaomu Cheng; Jinming Wang; Yuxiang Fang; Helen He Zhu; Chee Wai Chua; Liancheng Fan; Yinjie Zhu; Jiahua Pan; Jia Wang; Wei Xue; Wei-Qiang Gao
Journal:  Commun Biol       Date:  2020-12-16

3.  Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2.

Authors:  Qiuli Liu; Jian Pang; Lin-Ang Wang; Zhuowei Huang; Jing Xu; Xingxia Yang; Qiubo Xie; Yiqiang Huang; Tang Tang; Dali Tong; Gaolei Liu; Luofu Wang; Dianzheng Zhang; Qiang Ma; Hualiang Xiao; Weihua Lan; Jun Qin; Jun Jiang
Journal:  J Pathol       Date:  2020-11-05       Impact factor: 7.996

Review 4.  Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation.

Authors:  Stefan Werner; Gunhild von Amsberg; Lina Merkens; Verena Sailer; Davor Lessel; Ella Janzen; Sarah Greimeier; Jutta Kirfel; Sven Perner; Klaus Pantel
Journal:  J Exp Clin Cancer Res       Date:  2022-02-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.